Intrexon Buys Agarigen, Creates AgBio Division | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Synthetic biology firm Intrexon today announced it has formed its Agricultural Biotechnology Division and acquired Agarigen for an undisclosed amount.

Matthew Crisp, formerly a managing director at investment firm Third Security, was appointed president of the AgBio Division and a senior vice president of Intrexon.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.